Initial evaluation in the climacteric

References
1 Utian WH. Ovarian function, therapy-oriented definition of menopause and climacteric. Exp Gerontol 1994; 29 (3-4): 245-51
2 Ministério da Saúde. Instituto Sírio-Libanês de Ensino e Pesquisa. Protocolos da atenção básica: saúde das mulheres. Brasília (DF): Ministério da Saúde; 2016
3 Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW. et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 2012; 97 (04) 1159-68
4 Welt CK. Ovarian development and failure (menopause) in normal women [Internet]. 2020 [cited 2020 Jun 21]. Available from: https://www.uptodate.com/contents/ovarian-development-and-failure-menopause-in-normal-women
5 Federação Brasileira das Associações de Ginecologia e Obstetrícia. Insuficiência ovariana prematura. São Paulo: Febrasgo; 2021. . (Protocolo Febrasgo-Ginecologia, no. 26/Comissão Nacional Especializada em Ginecologia Endócrina)
6 Shifren JL, Gass ML. NAMS Recommendations for Clinical Care of Midlife Women Working Group. The North American Menopause Society recommendations for clinical care of midlife women. Menopause 2014; 21 (10) 1038-62
7 Voda AM. Climacteric hot flash. Maturitas 1981; 3 (01) 73-90
8 Kaunitz AM, Manson JE. Management of menopausal symptoms. Obstet Gynecol 2015; 126 (04) 859-76
9 Casper RF. Clinical manifestations and diagnosis of menopause [Internet]. 2020 [cited 2020 Jun 21]. Available from: https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-menopause
10 Ministério da Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2020: incidência de câncer no Brasil [Internet]. Rio de Janeiro: INCA; 2019. [cited 2020 Jun 1]. Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//estimativa-2020-incidencia-de-cancer-no-brasil.pdf
11 Pompei LM, Machado RB, Wender MC, Fernandes CE. Consenso Brasileiro de Terapêutica Hormonal da Menopausa – Associação Brasileira de Climatério (Sobrac). São Paulo: Leitura Médica; 2018
12 Siu AL. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2016; 164 (04) 279-96
13 Urban LA, Chala LF, Bauab SP, Schaefer MB, Santos RP, Maranhão NM. et al. Breast cancer screening: updated recommendations of the Brazilian College of Radiology and Diagnostic Imaging, Brazilian Breast Disease Society, and Brazilian Federation of Gynecological and Obstetrical Associations. Radiol Bras 2017; 50 (04) 244-9
14 Committee on Practice Bulletins - Gynecology. Practice Bulletin Number 179: breast cancer risk assessment and screening in average-risk women. Obstet Gynecol 2017; 130 (01) e1-e16
15 Ministério da Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva. Diretrizes brasileiras para o rastreamento do câncer do colo do útero [Internet]. 2a ed.. Rio de Janeiro: INCA; 2016. [cited 2020 Jun 21]. Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//diretrizesparaorastreamentodocancerdocolodoutero_2016_corrigido.pdf
16 Federação Brasileira das Associações de Ginecologia e Obstetrícia. Rastreio, diagnóstico e tratamento do câncer de colo de útero. São Paulo: Febrasgo; 2017
17 Menon U, Gentry-Maharaj A, Burnell M, Singh N, Ryan A, Karpinskyj C. et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet 2021; 397 (10290): 2182-93
18 Pinsky PF, Yu K, Kramer BS, Black A, Buys SS, Partridge E. et al. Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up. Gynecol Oncol 2016; 143 (02) 270-5
19 Chen L, Berek JS. Endometrial carcinoma: clinical features, diagnosis, prognosis, and screening [Internet]. 2021 [cited 2021 Jul 12]. Available from: https://www.uptodate.com/contents/endometrial-carcinoma-clinical-features-diagnosis-prognosis-and-screening
20 Committee Opinion No. 716: the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer in women at average risk. Obstet Gynecol 2017; 130 (03) e146-9
21 Wolf AM, Fontham ET, Church TR, Flowers CR, Guerra CE, LaMonte SJ. et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin 2018; 68 (04) 250-81
22 World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. Geneva: WHO; 2013
23 Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Rastreamento [Internet]. Brasília (DF): Ministério da Saúde; 2010. [cited 2020 Jun 23]. (Caderno de Atenção Básica; no. 29). Available from: http://189.28.128.100/dab/docs/publicacoes/cadernos_ab/abcad29.pdf
24 Lobo RA. Hormone-replacement therapy: current thinking. Nat Rev Endocrinol 2017; 13 (04) 220-31
25 Précoma DB, Oliveira GM, Simão AF, Dutra OP, Coelho OR, Izar MC. et al. Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology – 2019. Arq Bras Cardiol 2019; 113 (04) 787-891
26 Rosen HN, Drezner MK. Clinical manifestations, diagnosis, and evaluation of osteoporosis in postmenopausal women [Internet]. 2020 [cited 2020 Jun 21]. Available from: https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-evaluation-of-osteoporosis-in-postmenopausal-women
27 Albergaria BH, Paula FJ. The Algorhytm: FRAX Brazil. Rev Bras Ginecol Obstet 2019; 41 (08) 467-8
28 Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S. et al. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int 2014; 25 (10) 2359-81
29 Maki PM, Kornstein SG, Joffe H, Bromberger JT, Freeman EW, Athappilly G. et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause 2018; 25 (10) 1069-85
30 Santos IS, Tavares BF, Munhoz TN, Almeida LS, Silva NT, Tams BD. et al. Sensibilidade e especificidade do Patient Health Questionnaire-9 (PHQ-9) entre adultos da população geral. Cad Saúde Pública 2013; 29 (08) 1533-43
31 Heinemann LA, Potthoff P, Schneider HP. International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcomes 2003; 1: 28
32 Baill IC, Castiglioni A. Health maintenance in postmenopausal women. Am Fam Physician 2017; 95 (09) 561-70
33 Brenta G, Vaisman M, Sgarbi JA, Bergoglio LM, Andrada NC, Bravo PP. et al. Clinical practice guidelines for the management of hypothyroidism. Arq Bras Endocrinol Metabol 2013; 57 (04) 265-91
34 Mohammed K, Abu Dabrh AM, Benkhadra K, Al Nofal A, Carranza Leon BG, Prokop LJ. et al. Oral vs transdermal estrogen therapy and vascular events: a systematic review and meta-analysis. J Clin Endocrinol Metab 2015; 100 (11) 4012-20
35 Goff Jr DC, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R. et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129 (25 Suppl 2): S49-73
36 Archer DF, Pickar JH, Bottiglioni F. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group. Obstet Gynecol 1994; 83 (5 Pt 1): 686-92
37 Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 2013; 20 (09) 888-902